Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
25.75
-0.39 (-1.49%)
Feb 4, 2026, 9:43 AM EST - Market open
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $2.03 billion as of February 4, 2026. Its market cap has increased by 382.27% in one year.
Market Cap
2.03B
Enterprise Value
1.73B
1-Year Change
382.27%
Ranking
Category
Stock Price
$25.75
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has increased from $1.79B to $2.03B, an increase of 12.87%. That is a compound annual growth rate of 2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 2.06B | 4.56% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.18B |
| Recursion Pharmaceuticals | 2.18B |
| Sarepta Therapeutics | 2.17B |
| Ascentage Pharma Group International | 2.14B |
| Aurinia Pharmaceuticals | 2.01B |
| Ocular Therapeutix | 1.95B |
| Sionna Therapeutics | 1.95B |
| Nuvation Bio | 1.93B |